Email address
[email protected]Contact number
+1 650 843 5654Share profile
Band 2
Provided by Chadwick Mills
Chadwick focuses on corporate and securities law, and he regularly acts as outside corporate counsel to public life sciences companies. Chad provides ongoing compliance and strategic advice to biotechnology, pharmaceutical and device companies and their boards of directors on a wide range of securities, corporate and investor outreach matters, including financial reporting and disclosure issues, shareholder engagement and activism, securities offerings and corporate governance matters, in each case based on his extensive experience in the public life sciences space.
Chad has worked with or served as primary outside counsel to numerous current and former public life sciences clients, including: AcelRx Pharmaceuticals, BioMarin Pharmaceutical, Cerus Corporation, Conor Medsystems, Exelixis, Geron Corporation, GTx, Jazz Pharmaceuticals, Kosan Biosciences, Medivation, Molecular Devices, Rigel Pharmaceuticals, Seattle Genetics and Threshold Pharmaceuticals.
Chad has represented issuers in more than 30 public company financings and initial public offerings during the past five years, including:
* BioMarin Pharmaceutical in its $720 million public offering of common stock
* Seattle Genetics in its $552 million public offering of common stock
* Jazz Pharmaceuticals in its $575 million aggregate principal amount of exchangeable senior notes
* Multiple other issuers in public offerings and private placements of equity and convertible debt securities
Provided by Chambers
Chadwick Mills is held in particularly high regard for his expertise in acting for life sciences companies, which call upon his expert advice in securities and shareholder engagement matters.
Provided by Chambers
He has lot of life science clients so he has a really good sense of what other companies are doing and can offer advice on those niche areas. He's very knowledgeable in the law and he's practical.
We go to him with the things that are complicated and nuanced. The advice he gives is measured and realistic for our risk profile and the size and scale of our company.
He's a great board-facing advisor. He really knows how to handle the personalities on a board.
He's unflappable. He's able to handle tricky situations calmly and give good counsel to me and other members of the executive team. He's a very good communicator.
He has lot of life science clients so he has a really good sense of what other companies are doing and can offer advice on those niche areas. He's very knowledgeable in the law and he's practical.
We go to him with the things that are complicated and nuanced. The advice he gives is measured and realistic for our risk profile and the size and scale of our company.
He's a great board-facing advisor. He really knows how to handle the personalities on a board.
He's unflappable. He's able to handle tricky situations calmly and give good counsel to me and other members of the executive team. He's a very good communicator.